GRFS - Grifols, S.A.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
19.90
-0.22 (-1.09%)
At close: 4:00PM EDT

20.07 +0.17 (0.85%)
Pre-Market: 6:33AM EDT

Stock chart is not supported by your current browser
Previous Close20.12
Open19.85
Bid20.06 x 1800
Ask20.11 x 4000
Day's Range19.60 - 19.92
52 Week Range17.42 - 22.05
Volume918,095
Avg. Volume997,443
Market Cap17.002B
Beta (3Y Monthly)0.95
PE Ratio (TTM)33.19
EPS (TTM)0.60
Earnings DateN/A
Forward Dividend & Yield0.35 (1.75%)
Ex-Dividend Date2019-06-07
1y Target Est21.25
Trade prices are not sourced from all markets
  • PR Newswire8 days ago

    Grifols to launch plasma-protein-based bleeding-control solutions

    BARCELONA, Spain, June 19, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that the VISTASEAL™ fibrin sealant will be the first product it will introduce with Ethicon Inc. as part of a broad global relationship to provide plasma-protein-based solutions to manage surgical bleeding. Grifols developed VISTASEAL™, which combines two plasma proteins, fibrinogen and thrombin, and is administered with Ethicon's airless spray device technology.

  • Is Rigel Pharmaceuticals a Buy?
    Motley Fool15 days ago

    Is Rigel Pharmaceuticals a Buy?

    The stock rose after a promising full-year 2018 earnings report and then rapidly began sliding back to multiyear lows. What's going on?

  • Do Institutions Own Grifols, S.A. (BME:GRF) Shares?
    Simply Wall St.21 days ago

    Do Institutions Own Grifols, S.A. (BME:GRF) Shares?

    Every investor in Grifols, S.A. (BME:GRF) should be aware of the most powerful shareholder groups. Insiders often own...

  • George Soros' Top 6 New Buys of the 1st Quarter
    GuruFocus.comlast month

    George Soros' Top 6 New Buys of the 1st Quarter

    Top buys include entertainment company Comcast and homebuilder D.R. Horton

  • GRFS or ORINY: Which Is the Better Value Stock Right Now?
    Zacks2 months ago

    GRFS or ORINY: Which Is the Better Value Stock Right Now?

    GRFS vs. ORINY: Which Stock Is the Better Value Option?

  • Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript

    RIGL earnings call for the period ending March 31, 2019.

  • PR Newswire2 months ago

    Grifols Announces PharmacyKeeper Bidirectional Integration with Epic

    BARCELONA, Spain, April 30, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers, announced today that its PharmacyKeeper Verification IV Workflow Management system now supports bidirectional integration with Epic.

  • PR Newswire2 months ago

    Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia

    Investing $1.6 million into local community; set to employ over 40 people from the local area HINESVILLE, Ga. , April 29, 2019 /PRNewswire/ -- Grifols is pleased to announce the opening of a new Biotest ...

  • What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You?
    Simply Wall St.2 months ago

    What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You?

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we'll show how Grifols, S.A.'s (BME:GRF) P/E ratio could help you assess the value on offer...

  • PR Newswire2 months ago

    Grifols US donor centers exceed 250,000 pounds of food collected

    - About 20% of children in the U.S. are frequently hungry while nearly 50 million Americans do not get enough to eat. RALEIGH, N.C., April 18, 2019 /PRNewswire/ -- Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its U.S. network of over 220 donor centers collaborated with local food banks and pantries to collect more than 250,000 pounds of groceries to help address food insecurity in local communities. According to Feeding America, a leading national hunger non-profit, the 253,000 pounds of food collected translates into 211,000i meals to help support the over 50,000 familiesii that cannot put sufficient food on the table.

  • Grifols donations of blood clotting factor helping people with hemophilia globally
    PR Newswire2 months ago

    Grifols donations of blood clotting factor helping people with hemophilia globally

    - The company has donated more than 100 million international units (IUs) of blood clotting factor medicines globally during multi-year commitment to the WFH in developing regions. - Grifols creates Grifols Humanitarian Awards in Hemophilia to strengthen the global fight against the disease. BARCELONA, Spain, April 15, 2019 /PRNewswire/ -- Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its long-term global initiative to providing treatment to people with hemophilia in developing regions has surpassed 100 million international units (IUs) in donated blood clotting factor, a protein in blood that controls bleeding.

  • PR Newswire3 months ago

    Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019

    BARCELONA, Spain , April 5, 2019 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS) announced that it has filed its 2018 Annual Report on Form 20-F with the United ...

  • Grifols, S.A. (BME:GRF): What We Can Expect From This Growth Stock
    Simply Wall St.3 months ago

    Grifols, S.A. (BME:GRF): What We Can Expect From This Growth Stock

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Looking at Grifols, S.A.'s (BME:GRF) earnings update in December 2018, the cons...

  • Should You Buy Grifols SA (GRFS)?
    Insider Monkey3 months ago

    Should You Buy Grifols SA (GRFS)?

    "October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87\. For perspective, there have been only 5 occasions in those 40 years when the S&P 500 declined by greater than 20% from […]

  • PR Newswire3 months ago

    Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR

    Investing $1.8 million into local community; set to employ over 40 people from the local area RUSSELLVILLE, Ark. , March 23, 2019 /PRNewswire/ -- Grifols is pleased to announce the opening of a new Biotest ...

  • Reuters4 months ago

    Spain's Grifols, China's Shanghai RAAS form strategic alliance

    Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China. Under the agreement, the Catalan company will take a 26.2 percent stake in Shanghai RAAS in exchange for a stake of 45 percent (with 40 percent voting rights) in its U.S. division Grifols Diagnostic Solutions (GDS). Grifols said that no external financing was required to fund the transaction which is expected to close in the second half of 2019 pending regulatory approval.

  • Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript
    Motley Fool4 months ago

    Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript

    RIGL earnings call for the period ending December 31, 2018.

  • Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year
    PR Newswire4 months ago

    Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year

    This marks the third consecutive year the PharmacyKeeper Verification software has been recognized as the leader in the IV Workflow Management category by KLAS Research, a healthcare IT data and insight-gathering company that collects and publishes impartial research on the software and services used by healthcare providers and payers worldwide. The PharmacyKeeper suite of software applications was developed by MedKeeper, which was acquired by Grifols in January, 2018.

  • 'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner
    American City Business Journals4 months ago

    'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner

    After the FDA warned about "young blood" purporting to treat a range of diseases, including Alzheimer's and post-traumatic stress disorder, a company with a clinical operation in San Francisco has ceased its treatments.

  • East Bay biotech with late-stage drug files for bankruptcy
    American City Business Journals4 months ago

    East Bay biotech with late-stage drug files for bankruptcy

    Over 28 years, the company spent a half-billion dollars on developing inhaled lung-disease drugs that fell short of FDA approval.

  • Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
    PR Newswire5 months ago

    Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System

    BARCELONA, Spain, Feb. 7, 2019 /PRNewswire/ -- Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) approved the Procleix Babesia assay, a qualitative assay for the detection of the ribosomal RNA from 4  Babesia species (B. microti, B. duncani, B. divergens, B. venatorum) in individual samples or up to 16 pooled lysed specimens from human donors, including donors of whole blood and blood components for transfusion.

  • What To Know Before Buying Grifols, S.A. (BME:GRF) For Its Dividend
    Simply Wall St.5 months ago

    What To Know Before Buying Grifols, S.A. (BME:GRF) For Its Dividend

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Dividends play an important role in compounding Read More...

  • Benzinga5 months ago

    Rigel Rises On European Marketing Agreement For Autoimmune Drug

    Small-cap biotech Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL )'s shares were advancing Wednesday after it announced an agreement to commercialize fostamatinib, its autoimmune disorder drug. What Happened ...